Jilin Province Xidian Pharmaceutical Sci-Tech Development (301130.SZ) main shareholder Hengqin Dingdian and its concerted action party have completed the reduction of 757,400 shares.
West Point Pharmaceutical Co., Ltd. (301130.SZ) announced that its shareholder, Hengqin Dingdian Equity Investment Fund Partnership, holds more than 5% of the company's shares.
Announcement of Jilin Province Xidian Pharmaceutical Sci-Tech Development (301130.SZ): Shareholders holding more than 5% of the company, Hengqin Dingdian Equity Investment Fund Partnership Enterprise (Limited Partnership) (referred to as "Hengqin Dingdian") and its concerted action person Zhuhai Hengqin Runhuiyi Investment Partnership Enterprise (Limited Partnership) (formerly known as Hengqin Runhuiyi Equity Investment Fund Partnership Enterprise (Limited Partnership)) (referred to as "Zhuhai Hengqin Runhuiyi"), have collectively reduced their shares by 757,400 shares, accounting for 0.99% of the total share capital. The implementation of this reduction plan has been completed.
Related Articles
CHINA COME RIDE(08039) suspends trading from 9:00 am on July 2nd.
CLASSIFIED GP(08232): Suspension from trading starting from July 2nd pending the release of insider information.
MNSO(09896) spent $235,700 to repurchase 51,200 shares on July 1st.
CHINA COME RIDE(08039) suspends trading from 9:00 am on July 2nd.
CLASSIFIED GP(08232): Suspension from trading starting from July 2nd pending the release of insider information.
MNSO(09896) spent $235,700 to repurchase 51,200 shares on July 1st.
